In children with acute leukemia who require transplantation, using umbilical cord blood that is human leukocyte antigens (HLA)-matched, or which has one or two mismatched antigens, produces similar 5-year leukemia-free survival rates, according to the results of a study published in the June 9 issue of the Lancet.
In children with acute leukemia who require transplantation, using umbilical cord blood that is human leukocyte antigens (HLA)-matched, or which has one or two mismatched antigens, produces similar 5-year leukemia-free survival rates, according to the results of a study published in the June 9 issue of the Lancet.
John E. Wagner, MD, of the University of Minnesota in Minneapolis, and colleagues analyzed data on 503 children under 16 years of age who had acute leukemia and received umbilical cord blood transplants, and 282 children with the same disease who underwent bone marrow transplantation.
Among the cord blood recipients, only 35 received HLA-matched blood, whereas 201 received blood with one mismatched antigen and 267 received blood with two mismatched antigens. Among the three groups, those who received blood with two mismatched antigens had the highest rate of transplant-related mortality, but relapse rates were lower.
In an accompanying editorial, Vanderson Rocha, MD, PhD, and Eliane Gluckman, MD, of the Hopital Saint Louis in Paris, France, add that the study data emphasizes "that an umbilical cord-blood graft should be searched for together with an unrelated allele-matched bone marrow."
Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369: 1947-1954.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More